Live Breaking News & Updates on Engager Therapeutics

Stay updated with breaking news from Engager therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Innate Pharma Announces Its Participation in Upcoming Investor Conferences

Innate Pharma Announces Its Participation in Upcoming Investor Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Sonia Quaratino , Company Annual Report On Form , French Financial Markets Authority , Exchange Commission , Goldman Sachs , Regulatory News , Euronext Paris , Chief Executive Officer , Executive Vice President , Chief Medical Officer , Yannis Morel , Chief Operating Officer , Arvind Sood , Annual Global Healthcare Conference , Annual Immune Cell Engager Virtual Conference , European Healthcare Summit Lyon , Engager Therapeutics , Innate Pharma , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document , Annual Report ,

Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conferences

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced members of its executive team are scheduled to participate in the upcoming conferences ....

United States , New York , Arthur Rouill , Sonia Quaratino , Henry Wheeler , French Financial Markets Authority , Exchange Commission , Goldman Sachs , Company Annual Report On Form , Regulatory News , Euronext Paris , Chief Executive Officer , Executive Vice President , Chief Medical Officer , Yannis Morel , Chief Operating Officer , Arvind Sood , Global Healthcare Conference , Annual Global Healthcare Conference , Annual Immune Cell Engager Virtual Conference , European Healthcare Summit Lyon , Engager Therapeutics , Innate Pharma , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document ,

Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting

Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Olivier Demaria , Charu Aggarwal , Lorenzo Falchi , Hirva Mamdani , Pierluigi Porcu , American Society Of Clinical Oncology , Exchange Commission , French Financial Markets Authority , Hoosier Cancer Research Network , Company Annual Report On Form , Regulatory News , Euronext Paris , American Society , Clinical Oncology , Poster Session , Hematologic Malignancies , Chronic Lymphocytic Leukemia , Monday June , Multicenter Trial Investigating , Preliminary Antineoplastic Activity , Patients With Relapsed , Non Hodgkin Lymphoma , Lung Cancer , Non Small Cell , Engager Therapeutics ,

Innate Pharma SA: Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting

Top line results of TELLOMAK Phase 2 trial in mycosis fungoides confirming promising clinical activity of lacutamab Two posters on IPH6501, Innate's second generation ANKET, for the treatment ....

United States , Pierluigi Porcu , Henry Wheeler , Charu Aggarwal , Olivier Demaria , Arthur Rouill , Lorenzo Falchi , Hirva Mamdani , American Society Of Clinical Oncology , Exchange Commission , French Financial Markets Authority , Hoosier Cancer Research Network , Company Annual Report On Form , B Cell Non Hodgkin , Euronext Paris , American Society , Clinical Oncology , Poster Session , Hematologic Malignancies Lymphoma , Chronic Lymphocytic Leukemia , Monday June , Multicenter Trial Investigating , Preliminary Antineoplastic Activity , Patients With Relapsed , Non Hodgkin Lymphoma , Lung Cancer Non Small Cell ,

Innate Pharma: Clarification Regarding SAR443579 Designation

Regulatory News:

Innate Pharma SA today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by Sanofi, it. ....

European Hematology Association , Exchange Commission , Company Annual Report On Form , French Financial Markets Authority , Regulatory News , Euronext Paris , Track Designation , Engager Therapeutics , Innate Pharma , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document , Annual Report ,